Trump’s 15% tariff on medicines will harm patients, say EU drugmakers | Pharmaceuticals industry | The Guardian
…The White House text of the deal has added to existing confusion over the position of pharmaceuticals in the trade deal, given that EU officials said on Monday that pharma exports to the US would remain duty free until the US had completed its section 232 investigation into pharmaceuticals and semiconductors…
Rate this:
Trump’s 15% tariff on medicines will harm patients, say EU drugmakers
Trade group says levy will reduce access, disrupt supply chains and cut R&DLisa O’Carroll (The Guardian)